Prognostic Significance of p53 and p21waf1/cip1 Immunoreactivity in Epithelial Cancers of the Ovary
- 31 December 1999
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 75 (3), 413-418
- https://doi.org/10.1006/gyno.1999.5601
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivityZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancerInternational Journal of Cancer, 1997
- Relationship of p53 genotype to second-look recurrence and survival in ovarian epithelial malignancyMolecular Diagnosis, 1996
- Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinomaCancer, 1995
- Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significanceBritish Journal of Cancer, 1994
- p53 Expression in Epithelial Ovarian Neoplasms: Relationship to Clinical and Pathological Parameters, Ki-67 Expression and Flow CytometryGynecologic Oncology, 1994
- Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical featuresBritish Journal of Cancer, 1994
- P53 mutation in a series of epithelial ovarian cancers from the U.K., and its prognostic significanceEuropean Journal Of Cancer, 1994
- p53 gene mutations and protein accumulation in human ovarian cancer.Proceedings of the National Academy of Sciences, 1993